Details for 2014200334
Up to date per 04.04.2026
Actions
Details for 2014200334
Granted/Registered
European Patent
27.01.2016 A
06.11.2019 B1
09.09.2010
US
403011 P
29.10.2010
US
456014 P
13.01.2011
US
201161432372 P
23.04.2011
WO
PCT/US2011/033699
C12N 9/18 20060101AFI20181023BHEP
Owner
Alexion Pharmaceuticals, Inc.121 Seaport Boulevard Boston, MA 02210US
Representative
Representative
Kliment & Henhapel Patentanwälte OGGonzagagasse 151010 WienAT
Inventor
Quinn, Anthony107 Manet Road Chestnut Hill, MA Massachusetts 02467US
Information about Fees